<DOC>
	<DOCNO>NCT01430975</DOCNO>
	<brief_summary>This study perform two clinical site patient receive CardioGen-82 time period January June , 2011 patient scan chronologically near index patient ( 2 day ) . Of , plan least 30 patient enter trial . Index patient term apply individual radiation spectra indicative Sr-82 Sr-85 detect hand-held survey meter .</brief_summary>
	<brief_title>Prospective Evaluation Strontium Patients After CardioGen-82 PET MPI Scanning Two Clinical Sites</brief_title>
	<detailed_description>This clinical study protocol use three tier approach consist follow examination : - Patient examination Survey Meter : The patient first test clinical site use survey meter . In patient whose radiation count ≥ 2 time background count use standard survey meter , presence Sr-82 and/or Sr-85 assess quantitative reading calibrate portable isotope identifier . - Patient examination Portable Isotope Identifier : This examination do use portable isotope identifier , supply Sponsor study site . An assessor , independent study site perform examination . In patient whose radiation count ≥ 2 time background count use standard survey meter , presence Sr-82 and/or Sr-85 assess quantitative reading calibrate portable isotope identifier . The reading forward along date reading , date patient 's CardioGen-82® scan , total dose CardioGen-82® administer patient , independent medical expert , independent study site , back-calculate estimate dose Sr-82 and/or Sr-85 data . - Patient examination Oak Ridge National Laboratory : Any patient whose estimate dose Sr-82 exceeds specify limit 0.02 microcuries per mCi Rb-82 administer , and/or whose estimate dose Sr-85 exceeds specify limit 0.2 microcuries per mCi Rb-82 administer , ask travel Oak Ridge National Laboratory Tennessee , accurate whole body scan . Scan data Oak Ridge National Laboratories analyze one independent medical expert accurately back-calculate exposure Sr-82 and/or Sr-85 , estimate health hazard patient .</detailed_description>
	<criteria>Male female ; Gave inform consent participate study ; Received CardioGen82 elute generator close proximity ( 2 day ) index patient . Any patient previously enrol complete study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Radiation Exposure</keyword>
	<keyword>Rubidium 82</keyword>
	<keyword>Strontium 82</keyword>
	<keyword>Strontium 85</keyword>
</DOC>